CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.
Reference intervals
APPROPRIATE VALUES ARE PROVIDED ON THE REPORT.
Clinical Utility
MONITORING TREATMENT RESPONSE, DISEASE PROGRESSION & ASSESSING RECURRENCE IN OVARIAN CANCER. LEVELS MAY ALSO BE ELEVATED IN OTHER CANCERS E.G. PANCREATIC, UTERINE CANCERS ETC.
Test Limitations/ Confounders
LEVELS MAY BE ELEVATED IN MULTIPLE BENIGN CONDITIONS E.G. ENDOMETRIOSIS, BENIGN OVARIAN CYSTS, HYPOTHYROIDISM, LIVER CIRRHOSIS, HEART FAILURE, NON-TUMORAL ASSAYS ETC. IMMUNOASSAY INTERFERENCE CAN GIVE RISE TO SPURIOUS RESULTS. SUCH INTERFERENCE CAN ARISE FROM PRESENCE OF HETEROPHILE ANTIBODIES, ANTI-ANIMAL ANTIBODIES, AUTOANTIBODIES, PARAPROTEINS, BIOTIN ETC. RESULTS SHOULD ALWAYS BE CORRELATED WITH CLINICAL FINDINGS.